Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2936 Neoplasms 174 Lung Neoplasms 149 Prostatic Neoplasms 116 Ovarian Neoplasms 113 Colorectal Neoplasms 106 Triple Negative Breast Neoplasms 98 Colonic Neoplasms 91 Neoplasm Metastasis 74 Melanoma 66 Carcinoma, Non-Small-Cell Lung 64 Pancreatic Neoplasms 63 Carcinoma, Intraductal, Noninfiltrating 60 Stomach Neoplasms 54 Head and Neck Neoplasms 47 Breast Cancer Female 45 Lymphedema 42 Uterine Cervical Neoplasms 40 Breast Carcinoma In Situ 35 Esophageal Neoplasms 34 Cardiotoxicity 34 Urinary Bladder Neoplasms 33 Motor Activity 33 Lymphoma 33 Endometrial Neoplasms 33 Breast Diseases 33 Fatigue 30 Rectal Neoplasms 28 Breast Neoplasms, Male 28 Multiple Myeloma 27

Interventions

Tablets 1 Genetic Testing 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hormone Receptor Positive Breast Cancer × Breast × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡